A majority of patients delaying care came from a low-income household.

Overall, the authors emphasized, TMVR helped heart failure patients with and without diabetes.

This is a Class I recall, which means the issue can lead to serious injury or death.

“Making these diagnoses earlier could allow for urgent intervention, preventing the cardiac remodeling and organ dysfunction that accompany delays in treatment,” the study's authors said. 

According to the study's authors, their findings suggest that "all patients with signs or symptoms of heart failure should be considered for rhythm control therapy within a year of being diagnosed with AFib."

Findings from the study may be helpful in conveying the benefits of dapagliflozin treatment to patients with HFrEF, the authors said. 

The digital therapeutic helps patients follow recommended treatment guidelines by monitoring their health data, connecting them to healthcare providers and personalizing their treatment when necessary.

"We thought that illicit drugs like cocaine or methamphetamine, which can lead to heart attacks, would prove to be dangerous,” one researcher said. "However, we were wrong."